Evidence map›Paper›PMID 42805995›Full record

ArticleNature communications2026

Why variant effect predictors and multiplexed assays agree and disagree.

Benjamin J Livesey, Joseph A Marsh

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Benjamin J LiveseyMRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK. blivesey@ed.ac.uk.ORCID http://orcid.org/0000-0001-6866-1452
Joseph A MarshMRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK. joseph.marsh@ed.ac.uk.ORCID http://orcid.org/0000-0003-4132-0628

Funding

RCUK | Medical Research Council (MRC) MC_UU_00035/9
6 · The paper itself

Abstract

Multiplexed assays of variant effect (MAVEs) and computational variant effect predictors (VEPs) are two key tools that provide evidence for the interpretation of genetic variants. While their outputs are often concordant, there are also many differences. Here, we analyse missense MAVE data from 40 different human proteins, comparing them to state-of-the-art VEPs in order to quantify and explain their points of agreement and disagreement. We find that discordance is not random but reflects fundamental differences in how each method infers variant effects. VEPs, which rely heavily on sequence conservation and basic structural features, tend to predict buried and bulky hydrophobic residues as more damaging, while underpredicting impact in disordered regions and at charged surface residues. MAVEs, by contrast, capture context-specific mechanisms more accurately, but can miss damaging variants when the assay fails to reflect disease biology, or be subject to high levels of experimental noise. By comparing both global patterns and specific clinically relevant variants, we show how protein features, assay design, and variant type shape prediction discordance. Our findings provide a framework for interpreting when and why MAVEs and VEPs diverge and point toward strategies for improving variant interpretation through integrated, mechanism-aware approaches.

Indexed as

Computational BiologyGenetic VariationProteinsHumansMutation, MissenseProteins

Identifiers

PMID42805995
PMCPMC13620131

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.